| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 12,137.0 | 11,122.0 |
| Profit before tax | 2,088.0 | 1,826.0 |
| Net income | 1,721.0 | 1,616.0 |
| EPS (diluted, $ a share) | $4.64 | $4.27 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +6.5% |
|---|---|
| Revenue, year on year | +9.1% |
| Operating margin | 18.6% |
10-Q filed with the SEC, NYSE: TMO. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Thermo Fisher Scientific Inc.: key numbers
- Share price
- $691.33Close, Nov 16
- Market cap
- $256B
- Shares outstanding
- 370.52MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Measuring & Controlling Devices, NECSIC 3829
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Thermo Fisher Scientific Inc.
All →Thermo Fisher Scientific President & COO Gianluca Pettiti Sells $2.9M of Stock
Gianluca Pettiti, President & COO, sold 4,133 shares of Thermo Fisher Scientific Inc. at $701.42 a share, worth $2.9M in total on Nov 13, 2026. Shares held after the trade: 22,816 (-14.1%).
- Value
- $2.9M
- Shares
- 4,133
- Average price
- $701.42
- Role
- President & COO
- Holding change
- -14.1%
- Trade date
- Nov 13, 2026
Thermo Fisher Scientific Sr. VP and Chief HR Officer Lisa P. Britt Sells $2M of Stock
Lisa P. Britt, Sr. VP and Chief HR Officer, sold 2,831 shares of Thermo Fisher Scientific Inc. at $706.45 a share, worth $2M in total on Oct 28, 2026. Shares held after the trade: 11,560 (-19.7%).
- Value
- $2M
- Shares
- 2,831
- Price
- $706.45
- Role
- Sr. VP and Chief HR Officer
- Holding change
- -19.7%
- Trade date
- Oct 28, 2026
Thermo Fisher Scientific Leadership Change
Thermo Fisher Scientific Inc. announced that Michael D. Shafer, Executive Vice President, will retire from the company effective December 31, 2026. This leadership transition represents a planned departure of a senior executive.
Thermo Fisher Scientific Financial Results
Thermo Fisher Scientific reported third-quarter 2026 revenue of $12.14 billion, representing 9% growth (6% organic) compared to the prior year. The company achieved GAAP diluted EPS of $4.64 and adjusted EPS of $6.68, driven by its growth strategy and the PPI Business System.
- Term
- Q3 2026
“We are very pleased to deliver another excellent quarter, with outstanding financial performance on both the top and bottom line. We’re advancing our proven growth strategy, which is resonating strongly with our customers, and our PPI Business System is enabling outstanding execution across the company.”
Marc N. Casper, chairman and chief executive officer of Thermo Fisher Scientific
“Looking ahead, we’re well positioned to deliver an excellent 2026 as we continue to drive long-term value creation for all of our stakeholders and build an even brighter future for our company.”
Marc N. Casper, chairman and chief executive officer of Thermo Fisher Scientific